Nearly half of people who started GLP-1 drugs like Ozempic or Wegovy say they now drink less alcohol, and among heavier drinkers it was over half (54%), according to a new national US survey of 2,000+ adults published in JAMA Psychiatry. The drugs may act on the brain's craving and reward pathways.
Read Full Article
#GLP1 #OzempicWegovy #AlcoholUseImpact
Read Full Article
#GLP1 #OzempicWegovy #AlcoholUseImpact
Jamanetwork
Patient-Reported Changes in Alcohol Use Following Glucagon-Like Peptide-1 Receptor Agonist Initiation
This survey study with a nationally representative sample evaluates whether individuals who initiate glucagon-like peptide-1 receptor agonists (GLP-1 RAs) report reducing alcohol consumption after starting the drug.
❤1🍾1